Avalo Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-06. The offering totals $10.0M, of which $6.8M was reported sold. Industry: Biotechnology.
Showing 25 of 52 people.
| Name | Role | Location |
|---|---|---|
| Sol F Barer | Director | Baltimore, MD |
| John A Catsimatidis | Director | Baltimore, MD |
| Cary W Sucoff, Jr. | Director | Baltimore, MD |
| John Kaiser | Executive Officer | Research Triangle Park, NC |
| Behshad Sheldon | Director | Malvern, PA |
| CHRISTOPHER SULLIVAN | Executive Officer | New York, NY |
| Eugene Bauer | Director | Redwood City, CA |
| Magnus Persson | Director | Beachwood, OH |
| June Almenoff, M.D., Ph.D. | Director | Rockville, MD |
| Mitchell Chan | Director | Rockville, MD |
| Jonathan Goldman, M.D. | Director | Rockville, MD |
| Aaron Kantoff | Director | Rockville, MD |
| Gilla Kaplan, Ph.D. | Director | Rockville, MD |
| Magnus Persson, M.D., Ph.D. | Director | Rockville, MD |
| Samantha Truex | Director | Rockville, MD |
| Garry Neil, M.D. | Director | Rockville, MD |
| Garry Neil, M.D. | Executive Officer | Rockville, MD |
| Thomas Aasen | Director | Research Triangle Park, NC |
| Uli Hacksell | Director | WAKE FOREST, NC |
| Uli Hacksell | Executive Officer | WAKE FOREST, NC |
| Mariam Morris | Executive Officer | Dallas, TX |
| Isaac Blech | Director | Jupiter, FL |
| Frank A Torti | Director | Menlo Park, CA |
| Isaac A Blech | Director | CITY OF INDUSTRY, CA |
| PHIL E GUTRY | Director | BALTIMORE, MD |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-04-09 | D | $200.0M | $130.6M |
| 2017-05-08 | D | $5.0M | $5.0M |
| 2016-09-16 | D | $15.0M | $1.0M |
| 2014-07-21 | D | $33.3M | $16.3M |
| 2012-04-04 | D | $22.5M | $22.1M |